IGF2 and hepatocellular carcinoma: The determination of serum insulin-like growth factor-II (IGF-II) (at the cut-off value of 4.1 mg/g, prealbumin) has a sensitivity of 63%, specificity of 90%, and accuracy of 70% in the diagnosis of small HCC [41].